When SVCT2 heterozygous mice are intercrossed with a mouse model of Alzheimer’s disease, an aggravation of amyloid pathology and cognition impairment occurs (Dixit et al., 2015). The gene discussed is SLC23A2; the disease is early-onset autosomal dominant Alzheimer disease.